openPR Logo
Press release

Why the Immunology Biosimilars Market is set to explode? Top Companies : Amgen, Novartis, Allergan, Merck Animal Health and more

07-01-2019 01:42 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fortune Business Insights

Why the Immunology Biosimilars Market is set to explode? Top

The Global Immunology Market is likely to expand in the coming years driven by the high prevalence of immunological disorders, resulting from environmental factors. According to a report published by Fortune Business Insights, titled “IMMUNOLOGY: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026,” the market was valued at US$ 77,365.4 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 143,833.2 Mn by 2026 and will exhibit a CAGR of 8.1%.

Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunology-market-100657

Some of the major companies that are present in the Global Immunology Market are;

• AbbVie
• The Janssen Pharmaceutical Companies of Johnson & Johnson
• F. Hoffmann-La Roche Ltd
• Amgen
• Pfizer
• Novartis
• Astellas Pharma US
• Bristol-Myers Squibb
• Merck Animal Health
• UCB SA
• Allergan
• Other Prominent Players

The global immunology market is likely to expand in the coming years driven by the high demand for immunology drugs resulting from the high prevalence of immunological disorders. The severity of immunological disorders has created an increasing awareness around the world. Various initiatives and advisory programs have been conducted by the government as well as public organizations. This, in turn, will fuel the demand for immunology drugs. Furthermore, the increased efficiency of immunology drugs has contributed to better patient outcomes, which in turn has led to subsequent growth of the global immunology market.

Recent Product Approvals by Regulatory Agencies to Bode Well for the Overall Market

The spate of recent regulatory approvals for the immunology products is anticipated to contribute to the overall positive growth of the market. For instance, the recent regulatory approval and the subsequent launch of TREMFYA (Guselkumab) by Janssen Global Services, LLC (Johnson & Johnson), is expected to lead to better outcome for the patients. TREMFYA (Guselkumab) was launched for the treatment of moderate to severe plaque psoriasis, a seriously debilitating immunological disorder. TREMFYA is the only biologic approved for the treatment of moderate to severe plaque psoriasis, that selectively blocks the interleukin (IL)-23, leading to a vast improvement in the symptoms of the patient. Apart from being one of the emerging drugs of the immunology market, Fortune Business Insights predicts that Janssen Global Services, LLC (Johnson & Johnson) latest product offering will have a positive impact on the global immunology market in the forthcoming years

AbbVie Gains FDA Approval of SKYRIZI; Product to Witness High Demand in No Time

The global immunology market has gained impetus from the availability of several regulatory approved drugs. The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology market. In 2019, AbbVie received approval from the Food and Drug Administration (FDA) for the usage of ‘SKYRIZI’. The drug was aimed at the treatment of moderate to severe plaque psoriasis. This drug was inclined towards the treatment of adults diagnosed with psoriasis and have been recommended for or undergoing therapy. The drug is likely to gain huge popularity among healthcare professionals and its high clinical efficacy will fuel the demand in the coming years.

Besides product launches and drug approvals, Fortune Business Insights assesses several other factors that have made significant growth contributions to the global immunology market. Companies are encouraged by the growing usage approvals by regulatory authorities across the world. Several company mergers and acquisitions have also accounted for growth of the global immunology market. Some of the leading companies that are operating in the global immunology market are AbbVie Inc., Janssen Global Services, LLC (Johnson & Johnson), F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc, Novartis AG, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and ALLERGAN.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/immunology-market-100657

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Why the Immunology Biosimilars Market is set to explode? Top Companies : Amgen, Novartis, Allergan, Merck Animal Health and more here

News-ID: 1792720 • Views:

More Releases from Fortune Business Insights

Reverse Flame Steam Boiler Market 2023 Dynamics, Major Players, SWOT Analysis, a …
Overview of the Global Reverse Flame Steam Boiler Market 2030: The report discusses everything a marketer requires before investing in the global Reverse Flame Steam Boiler Market during the forecast period 2023-2030. Reverse Flame Steam Boiler Market Size, Share And Global Trend By Capacity (Up to 100kW, 100-1000 kW, Above 1000 kW), By End-Use (Food Industry, Chemical Industry, Refineries, Metal Industry, Power Plant), And Geography Forecast Till 2022-2029. It provides detailed
Syngas and Derivatives Market Research Analysis, Size, Share, Growth Highlights …
Overview of the Global Syngas and Derivatives Market 2030: The report discusses everything a marketer requires before investing in the global Syngas and Derivatives Market during the forecast period 2023-2030. Syngas and Derivatives Market Size, Share and Global Trend By Feedstock(Coal, Petroleum, Natural Gas, Biomass), By Technology(Partial Oxidation, Steam Reforming, Auto-Thermal Reforming, and others), By End User(Chemicals, Power Generation, Liquid Fuels, Gaseous Fuels), and Geography Forecast till 2022-2029. It provides detailed
Port equipment Market Will Experience An Upswing In Demand, Driven By Top Players | Liebherr (Switzerland), TTS Group (Norway), Kalmar (Finland) Konecranes (Finland) |
Port equipment Market Will Experience An Upswing In Demand, Driven By Top Player …
The Port equipment Market Research Report provides an in-depth analysis of the market landscape and identifies future growth opportunities and trends until 2030. By offering valuable insights, the report enables companies to make informed decisions on business strategies and identify potential areas for growth. With a comprehensive assessment of the market, it equips businesses with the necessary tools to stay ahead of the competition. With this Port equipment Market research report,
Modular Chillers Market to reach USD 6.13 billion by 2026, at a CARG of 6.2% | LG Electronics, Mitsubishi Electric Corporation , Haier Group, Midea Group
Modular Chillers Market to reach USD 6.13 billion by 2026, at a CARG of 6.2% | L …
The Modular Chillers Market Report 2023 by Fortune Business Insights provides a comprehensive overview of the market's latest trends, size, regulations, key players, and strategies. The report offers valuable insights into the market's sales and revenue, product type, applications, regions, and leading players. Modular Chillers Market report also covers key players and competitor analysis, providing a comprehensive understanding of the industry's commercial landscape. The report is useful for gaining insights

All 5 Releases


More Releases for Johnson

Urgent Care Apps Market 2019 Analysis by Johnson & Johnson (Johnson & Johnson He …
"the Global Urgent Care Apps market is accounted for $312.93 million in 2017 and is expected to reach $6,382.75 million by 2026 growing at a CAGR of 39.8%. Growing demand owing to growing focus on patient-centric healthcare delivery and increase in penetration of 3G and 4G networks are some key factors influencing the market growth. However, poor internet connectivity in developing countries is restricting the growth of the market. In
Global Erythropoietin Market 2019 - Amgen, Johnson & Johnson, Roche
This new report by Eon Market Research, titled “Global Erythropoietin Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Erythropoietin industry at a global as well as regional and country level. Key facts analyzed in this report include the Erythropoietin market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive
Biotechnology Market - Development Outlook 2025 | Pfizer, Johnson & Johnson
Global Biotechnology Market: Overview The global biotechnology market is mainly driven by the surge in the demand for food, depleting natural resources, government regulatory support, and technological advancements of various solutions to counter fatal diseases. The advent of stem cell technology, nanotechnology, and cloning has also propelled this market substantially and is expected to continue aiding to this market in the years to come. However, the dearth of awareness among consumers
Wet Tissues Market 2017- Johnson & Johnson, SC Johnson, Clorox, Beiersdorf, 3M
Apex Research, recently published a detailed market research study focused on the "Wet Tissues Market" across the global, regional and country level. The report provides 360° analysis of "Wet Tissues Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Wet Tissues industry, and estimates the future trend of Wet Tissues market on
Cytokines Market 2017 - AbbVie, Johnson & Johnson, GlaxoSmithKline, Sanofi
Apex Research, recently published a detailed market research study focused on the "Cytokines Market" across the global, regional and country level. The report provides 360° analysis of "Cytokines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Cytokines industry, and estimates the future trend of Cytokines market on the basis of this
Global Facial Wipes Sales Market 2017 - Beiersdorf, Johnson & Johnson, SC Johnso …
The Global Facial Wipes Sales Industry report gives a comprehensive account of the Global Facial Wipes Sales market. Details such as the size, key players, segmentation, SWOT analysis, most influential trends, and business environment of the market are mentioned in this report. The report features an up-to-date data on key companies product details, revenue figures, and sales. The business model strategies of the key firms in the Facial Wipes Sales